Literature DB >> 19483204

Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function.

Ravi V Shah1, Annabel A Chen-Tournoux, Michael H Picard, James L Januzzi.   

Abstract

AIMS: To examine relationships between cardiac troponin T (cTnT) and parameters of left ventricular (LV) structure and function in patients with acute destabilized heart failure (HF) with preserved LV ejection fraction. METHODS AND
RESULTS: In 44 patients with acute heart failure (HF) with preserved left ventricular (LV) ejection fraction, parameters of LV structure and function were assessed via comprehensive two-dimensional Doppler echocardiography. There was no correlation between cTnT and LV wall thickness, left atrial volume index, or transmitral E wave velocity or deceleration time. There were associations between cTnT and LV end-diastolic dimension (r = -0.34, P = 0.02) and LV mass index (r = 0.32; P = .04). A lower tissue Doppler Ea wave peak velocity was associated with higher cTnT concentrations (r = -0.90, P < 0.001). In multivariate analyses, only LV end-diastolic dimension (t = 2.2; P = 0.04), LV mass index (t = 2.3; P = .03), and tissue Doppler Ea wave peak velocity (t = -4.7; P < .001) emerged as significant predictors of cTnT.
CONCLUSION: In patients with HF with preserved LV ejection fraction, cTnT is strongly associated with the extent of LV relaxation abnormalities and LV mass.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483204      PMCID: PMC2733766          DOI: 10.1093/ejechocard/jep063

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  21 in total

1.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden.

Authors:  Teresa S M Tsang; Marion E Barnes; Bernard J Gersh; Kent R Bailey; James B Seward
Journal:  Am J Cardiol       Date:  2002-12-15       Impact factor: 2.778

2.  Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction.

Authors:  S H Poulsen; S E Jensen; K Egstrup
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

3.  Cardiac troponin I as diagnostic and prognostic marker in severe heart failure.

Authors:  L La Vecchia; G Mezzena; L Zanolla; M Paccanaro; L Varotto; C Bonanno; R Ometto
Journal:  J Heart Lung Transplant       Date:  2000-07       Impact factor: 10.247

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.

Authors:  C Löwbeer; S A Gustafsson; A Seeberger; F Bouvier; J Hulting
Journal:  Scand J Clin Lab Invest       Date:  2004       Impact factor: 1.713

6.  Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.

Authors:  Tamara B Horwich; Jignesh Patel; W Robb MacLellan; Gregg C Fonarow
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

7.  Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.

Authors:  Kai M Eggers; Lars Lind; Håkan Ahlström; Tomas Bjerner; Charlotte Ebeling Barbier; Anders Larsson; Per Venge; Bertil Lindahl
Journal:  Eur Heart J       Date:  2008-07-07       Impact factor: 29.983

8.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

Authors:  Michael R Zile; Catalin F Baicu; William H Gaasch
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

9.  Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.

Authors:  Francesca Mallamaci; Carmine Zoccali; Saverio Parlongo; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Graziella Bonanno; Pasquale Fatuzzo; Francesco Rapisarda; Giuseppe Seminara; Benedetta Stancanelli; Ignazio Bellanuova; Alessando Cataliotti; Lorenzo S Malatino
Journal:  Am J Kidney Dis       Date:  2002-07       Impact factor: 8.860

10.  Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling.

Authors:  R Lapu-Bula; A Robert; M De Kock; A M D'Hondt; J M Detry; J A Melin; J L Vanoverschelde
Journal:  Am J Cardiol       Date:  1998-09-15       Impact factor: 2.778

View more
  5 in total

Review 1.  Diagnosis and management of type II myocardial infarction: increased demand for a limited supply of evidence.

Authors:  Nathaniel R Smilowitz; Becky Naoulou; Steven P Sedlis
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

2.  Role of Cardiac Troponin Levels in Acute Heart Failure.

Authors:  Nicholas Wettersten; Alan Maisel
Journal:  Card Fail Rev       Date:  2015-10

Review 3.  Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.

Authors:  Damien Gruson; Frédéric Thys; Franck Verschuren
Journal:  Mol Diagn Ther       Date:  2011-12-01       Impact factor: 4.074

4.  Association of cardiac troponin T with left ventricular structure and function in CKD.

Authors:  Rakesh K Mishra; Yongmei Li; Christopher DeFilippi; Michael J Fischer; Wei Yang; Martin Keane; Jing Chen; Jiang He; Radhakrishna Kallem; Edward J Horwitz; Mohammad Rafey; Dominic S Raj; Alan S Go; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2013-01-04       Impact factor: 8.860

5.  Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease.

Authors:  Daniel Priksz; Mariann Bombicz; Balazs Varga; Andrea Kurucz; Rudolf Gesztelyi; Jozsef Balla; Attila Toth; Zoltan Papp; Zoltan Szilvassy; Bela Juhasz
Journal:  Int J Mol Sci       Date:  2018-09-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.